The concept is great and the execution is improving. Fails to record if you are not sedentary for most of the day. Therefore always records when sleeping. Values are consistently higher than my Manual BP device. Algorithm should be better at detecting good opportunities to take readings. If you take the picture as a baseline then comparing readings to this gives a trend. App lacks ability to export results to carry out detailed analysis. Support is poor when device has issues. Mine just decided one day it no longer wanted to charge. Aktiia were unhelpful citing outside of warranty, but still they could have at least done some trouble shooting to ascertain the issue. It could simply have been the charging base and I would have happily paid for a replacement. But no. Looking foward to the release of the HUAWEI D2, I think this may prove to be a better investment than the one I made with Aktiia.
Claim your business profile now and gain access to all features and respond to customer reviews.
Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed.
Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.See more
